Methimazole protection against oxidative stress induced by hyperthyroidism in graves' disease

Endocrine Regulations

Volumn 34, Issue 2, 2000, Pages 83-89

  Sewerynek, J ^a   Wiktorska, J ^a   Nowak, D ^a   Lewinski, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Conjugated dienes; Hyperthyroidism; Malondialdehyde; Methimazole; Oxidative stress; Schiff bases

Indexed keywords

MALONALDEHYDE; THIAMAZOLE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANTITHYROID AGENTS; AUTOANTIBODIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GRAVES DISEASE; HUMANS; IODIDE PEROXIDASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METHIMAZOLE; OXIDATIVE STRESS; THYROGLOBULIN; THYROTROPIN; THYROXINE; TRIGLYCERIDES; TRIIODOTHYRONINE;

EID: 0033836053     PISSN: 00137200     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ADEMOGLU A, GOKKUSU C, YARMAN S, AZIZLERLI H: The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol Res 38,P01-P04,1998
2. BABIOR BM, WOODMAN RC: Chronic granulomatous disease. Semin-Hematol 27,247-259,1990
3. BUCOLO G, DAVID H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19,476-182,1973
4. CELIK I, AKALIN S, ERBAS T: Serum levels of interleukin 6 and tumor necrosis factor-α in hyperthyroid patients before and after prophylthiouracyl treatment. Eur J Endocrinol 132,668-672,1995
5. CHIOVATO L, SANTINI F, PINCHERA A: Treatment of hyperthyroidism. Thyroid Intern 2,1-20,1995
6. DAVIES C, FAHIE-WILSON MN; Use of magnesium acetate in high-density lipoprotein cholesterol assay. Clin Chem 25,1510,1979
7. DREXHAGE H, ROTTERDAM MD: Review of the autoimmunological thyroid diseases. Pathogenetic mechanisms (In Polish). Thyroid Intern 4,1-12,1995
8. FERNANDEZ V, BARRIENTUS X, KIPREOS K, VALENZUELA A, VIDELA LA: Super radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 117,496-501,1985
9. GRUBECK-LOEBENSTEIN B, BUCHAN G, CHANTRY D, KASSAL H, LONDEI M, et al: Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-l á and interleukin-6. Clin Exp Immunol 77,324-330,1989
10. HEUFELDER AE, WENZEL BE, BAHN RS: Methimazole and propylthiouracil inhibit the oxygen free radicalinduced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts. J Clin Endocrinol Metab 40,720-723,1992
11. HICKS M, WONG LS, DAY RO: Antioxidant activity of propylthiouracil. Biochem Pharmacol 4,439-444,1992
12. HOPPICHLER F, SANDHOLZER C, MONCAYO R, UTERMANN G, KRAFT HG: Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels. Atheriosclerosis 115,65-71,1995
13. JOHNSON MA, TURNBULL DM: Mitochondrial oxidative enzyme activity in individual fiber types in hypo and hyperthyroid rat skeletal muscles. Quarterly J Exp Physiol 69,257-62,1984
14. LOPES-VIRELLA MF, STONE P, ELLIS S, COLWELL I: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23,882-884,1977
15. MANO T, IWASE K, HAYASHI R, HAYAKAWA N, UCHIMURA K, et al: Vitamin E and coenzym Q concentrations in the thyroid tissues of patients with various thyroid disorders. Am J Med Sci 315,230-232,1998
16. MANOT, SHINOHARA R, IWASE K, KOTAKE M, HAMADA M, et al: Changes in free radicals scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 29,351-354,1997
17. MANO T, SINOHARA R, SAWAI Y, ODA N, NISHIDA Y, et al: Changes in lipid peroxidation and free radical scavengers in the brain of hyper- and hypothyroid aged rats. J Endocrinol 147,361-365,1995
18. NOWAK D, ANTCZAK A, PIETRAST, BIALASIEWICZ P, KRÓL M: Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipid in mice. Free Rad Biol Med 19,659-663,1995
19. NOWAK D, PIETRAS T, ANTCZAK A, KRÓL M, PIASECKA G: Effect of bacterial lipopolysacharide on the content of lipid peroxidation products in lungs and other organs of mice. Anton van Leeuwenhoek 63,77-83,1993
20. ORGIAZZI J, MILLOT L: Theoretical aspects of the treatment with antithyroid drugs. Ann Endocrinol 55,1-5,1994
21. ORGIAZZI J, MORNEX R: Hyperthyroidism. In: Greer MA (ed): The Thyroid Gland, pp. 405-495. Raven Press, New York, 1990
22. PEREIRA B, COSTA ROSA LFBP, SAFI D, BECHARA EJH, CURI R:. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 140,73-77,1994
23. PIOTROWSKI WJ, PIETRAS T, KURMANOWSKA Z, NOWAK D, MARCZAK J, MARKS-KONCZALIK J, MAZERANT P: Effect of paraquat intoxication and ambroxol treatment on hydrogen peroxide production and lipid peroxidation in selected organs of rat. Appl Toxicology 16,501-507,1996
24. ROM-BOGUSLAVSKAIA ES, SOMOVA EV, OVSIANNIKOVA TN, DIAGELEVA EA, KARACHENTSEV IUI, ASAULA VA: Peroxide oxidation of lipids in the tissue of human thyroid in patients suffering from diffuse toxic goitre (in Ukrainian). Ukr Biokhm Zh 69,111-114,1997
25. ROODYN DB, FREEMAN KB, TATA JR: The stimulation by treatment in vivo with tri-iodothyronine or amino acid incorporation into protein by isolated rat liver mitochondria. Biochem J 94,6228-6241,1965
26. SCHRECK P, BAEUERLE PA: A role of oxygen radicals as second messengers. Trends Cell Biol 1,39-42,1991
27. SCHRECK P, RIEBER P, BAEUERLE PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription and HIV-1. EMBO J 10,2247-2258,1991
28. SEVENA, SEYMEN O, HATEMI S, HATEMI S, YIGIT G, CANDAN G: Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation. Clin Chim Acta 256,65-74,1996
29. SEVEN A, TASAN E, INCI F, HATEMI H, BURCAK G: Biochemical evaluation of oxidative stress in propylthiouracil treated hyperthyroid patients. Effects of vitamin C supplementation. Clin Chem Lab Med. 6,767-770,1998
30. SPANDRIO S, SLEIMAN I, SCALVINI T, SALVI A, DI-STEFANO O, PAGLIAINI R, BALESTRIERI GP: Lipoprotein(a) in thyroid dysfunction before and after treatment. Horm Metab Res 25,586-589,1993
31. VERDITTI P, DELEO T, DIMEO S: Vitamin E administration attenuates the tri-iodothyronine-induced of heart electrical activity in the rat. J Exp Biol 200,909-914,1997
32. VOLPE R: Graves' disease. In: Braverman LE, Utiger RD (eds): The Thyroid, pp. 648-652. JB Lippincott, Philadelphia, 1991
33. WARTOFSKY L: Has the use of antithyroid drugs for Graves' disease become obsolete. Thyroid 3,335-44,1993
34. WEETMAN AP, TANDON N, MORGAN BP: Antithyroid drugs and release of inflammatory mediators by complementattacked thyroid cells. Lancet 340,633-636,1992